SLC5A2 and liver dysplastic nodule: However, the long delay in DN healing, not present at 5 years [47], but demonstrable after 10 years of normoglycemia [46] makes it unlikely that rapid DN glomerulopathy reversal largely accounts for the clinical benefits of the SGLT2 inhibitors; it is more likely that these agents influence the progression of tubulointerstitial injury.